David Karasik
Concepts (559)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 37 | 2026 | 240 | 6.670 |
Why?
| | Bone Density | 54 | 2025 | 494 | 5.840 |
Why?
| | Genome-Wide Association Study | 75 | 2025 | 1537 | 4.720 |
Why?
| | Zebrafish | 26 | 2025 | 536 | 4.210 |
Why?
| | Bone and Bones | 20 | 2024 | 319 | 3.990 |
Why?
| | Polymorphism, Single Nucleotide | 60 | 2025 | 2240 | 2.760 |
Why?
| | Sarcopenia | 6 | 2024 | 100 | 1.690 |
Why?
| | Genetic Predisposition to Disease | 26 | 2021 | 2488 | 1.690 |
Why?
| | Musculoskeletal System | 5 | 2021 | 53 | 1.580 |
Why?
| | Phenotype | 28 | 2025 | 3206 | 1.560 |
Why?
| | Musculoskeletal Diseases | 4 | 2024 | 95 | 1.540 |
Why?
| | Aging | 20 | 2026 | 1996 | 1.400 |
Why?
| | Genetic Pleiotropy | 5 | 2019 | 37 | 1.340 |
Why?
| | Inheritance Patterns | 6 | 2017 | 49 | 1.300 |
Why?
| | Longevity | 11 | 2026 | 179 | 1.200 |
Why?
| | Anatomy | 2 | 2021 | 31 | 1.150 |
Why?
| | Body Composition | 4 | 2025 | 689 | 1.130 |
Why?
| | X-Ray Microtomography | 4 | 2024 | 117 | 1.050 |
Why?
| | Lipid Metabolism | 4 | 2024 | 533 | 1.050 |
Why?
| | Quantitative Trait Loci | 20 | 2021 | 388 | 1.050 |
Why?
| | Whole Genome Sequencing | 3 | 2025 | 183 | 1.010 |
Why?
| | Genetic Loci | 12 | 2021 | 273 | 0.980 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 5 | 2022 | 8 | 0.970 |
Why?
| | Fractures, Bone | 13 | 2025 | 436 | 0.920 |
Why?
| | Zebrafish Proteins | 4 | 2025 | 314 | 0.910 |
Why?
| | Genetic Variation | 8 | 2021 | 996 | 0.890 |
Why?
| | Animals | 52 | 2026 | 38107 | 0.860 |
Why?
| | Genome, Human | 9 | 2024 | 431 | 0.850 |
Why?
| | Hip | 6 | 2020 | 61 | 0.840 |
Why?
| | Quantitative Trait, Heritable | 5 | 2018 | 119 | 0.840 |
Why?
| | Genomics | 10 | 2023 | 853 | 0.800 |
Why?
| | Osteoclasts | 2 | 2023 | 56 | 0.770 |
Why?
| | Musculoskeletal Physiological Phenomena | 2 | 2021 | 8 | 0.760 |
Why?
| | Humans | 128 | 2026 | 146342 | 0.710 |
Why?
| | Oryzias | 1 | 2022 | 8 | 0.710 |
Why?
| | Disease Models, Animal | 10 | 2025 | 4580 | 0.710 |
Why?
| | Arginase | 1 | 2021 | 26 | 0.700 |
Why?
| | Genetic Markers | 3 | 2021 | 340 | 0.690 |
Why?
| | Bone Regeneration | 2 | 2019 | 28 | 0.690 |
Why?
| | Menarche | 6 | 2024 | 53 | 0.690 |
Why?
| | Anatomists | 1 | 2021 | 1 | 0.690 |
Why?
| | Urea | 1 | 2021 | 84 | 0.670 |
Why?
| | Muscles | 3 | 2022 | 330 | 0.670 |
Why?
| | Muscle, Skeletal | 7 | 2025 | 1818 | 0.620 |
Why?
| | Mobility Limitation | 1 | 2020 | 68 | 0.610 |
Why?
| | Absorptiometry, Photon | 10 | 2025 | 278 | 0.600 |
Why?
| | Bone Diseases, Metabolic | 1 | 2020 | 60 | 0.600 |
Why?
| | Body Fluid Compartments | 1 | 2019 | 6 | 0.580 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2599 | 0.570 |
Why?
| | Pelvic Bones | 2 | 2019 | 137 | 0.550 |
Why?
| | Calcification, Physiologic | 2 | 2025 | 28 | 0.540 |
Why?
| | Models, Animal | 4 | 2024 | 387 | 0.520 |
Why?
| | Finite Element Analysis | 1 | 2017 | 67 | 0.510 |
Why?
| | Gene Frequency | 6 | 2024 | 496 | 0.500 |
Why?
| | Dissection | 1 | 2017 | 58 | 0.500 |
Why?
| | Hypoxia | 2 | 2021 | 1211 | 0.500 |
Why?
| | Telomere Shortening | 1 | 2016 | 20 | 0.490 |
Why?
| | Starvation | 1 | 2016 | 21 | 0.490 |
Why?
| | RNA, Long Noncoding | 3 | 2025 | 174 | 0.460 |
Why?
| | Female | 75 | 2025 | 79499 | 0.460 |
Why?
| | Gene-Environment Interaction | 2 | 2016 | 190 | 0.450 |
Why?
| | Peer Group | 1 | 2017 | 251 | 0.440 |
Why?
| | Adipose Tissue | 2 | 2019 | 642 | 0.430 |
Why?
| | Alkaline Phosphatase | 2 | 2018 | 144 | 0.430 |
Why?
| | Oxidative Stress | 1 | 2021 | 1369 | 0.430 |
Why?
| | Leukocytes | 1 | 2016 | 301 | 0.430 |
Why?
| | Teaching | 1 | 2017 | 244 | 0.430 |
Why?
| | Education, Medical, Undergraduate | 1 | 2017 | 208 | 0.420 |
Why?
| | Linkage Disequilibrium | 8 | 2020 | 260 | 0.410 |
Why?
| | Male | 60 | 2025 | 73396 | 0.400 |
Why?
| | Methyltransferases | 1 | 2014 | 74 | 0.400 |
Why?
| | Cohort Studies | 22 | 2021 | 6077 | 0.380 |
Why?
| | Telomere | 1 | 2016 | 300 | 0.380 |
Why?
| | Genetic Linkage | 4 | 2010 | 271 | 0.380 |
Why?
| | Bone Diseases | 3 | 2021 | 60 | 0.370 |
Why?
| | Aged | 34 | 2025 | 26432 | 0.370 |
Why?
| | Students, Medical | 1 | 2017 | 383 | 0.360 |
Why?
| | Physicians | 1 | 2021 | 955 | 0.360 |
Why?
| | Chromosome Mapping | 4 | 2010 | 508 | 0.360 |
Why?
| | Membrane Proteins | 6 | 2024 | 1130 | 0.360 |
Why?
| | Gene Regulatory Networks | 6 | 2021 | 319 | 0.360 |
Why?
| | GATA Transcription Factors | 1 | 2012 | 7 | 0.350 |
Why?
| | Femur | 6 | 2020 | 264 | 0.350 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2021 | 56 | 0.330 |
Why?
| | Middle Aged | 39 | 2025 | 36619 | 0.330 |
Why?
| | Reference Standards | 2 | 2024 | 176 | 0.330 |
Why?
| | Body Size | 3 | 2020 | 91 | 0.330 |
Why?
| | Mice | 19 | 2026 | 18297 | 0.320 |
Why?
| | Myoblasts | 2 | 2026 | 84 | 0.320 |
Why?
| | Phosphate Transport Proteins | 1 | 2010 | 2 | 0.320 |
Why?
| | Signal Transduction | 6 | 2024 | 5246 | 0.320 |
Why?
| | Lumbar Vertebrae | 7 | 2022 | 260 | 0.320 |
Why?
| | Genotype | 17 | 2021 | 1879 | 0.320 |
Why?
| | NF-kappa B | 1 | 2014 | 674 | 0.310 |
Why?
| | Pyrophosphatases | 1 | 2010 | 28 | 0.310 |
Why?
| | Haplotypes | 4 | 2024 | 506 | 0.310 |
Why?
| | Vitamin D | 5 | 2023 | 402 | 0.310 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2010 | 53 | 0.310 |
Why?
| | Spinal Fractures | 4 | 2016 | 81 | 0.310 |
Why?
| | Osteoporotic Fractures | 3 | 2018 | 62 | 0.310 |
Why?
| | Puberty | 2 | 2024 | 141 | 0.300 |
Why?
| | Spine | 4 | 2022 | 184 | 0.300 |
Why?
| | Femur Head | 2 | 2020 | 45 | 0.290 |
Why?
| | Multifactorial Inheritance | 4 | 2025 | 243 | 0.280 |
Why?
| | Durapatite | 2 | 2019 | 36 | 0.280 |
Why?
| | Metacarpal Bones | 1 | 2008 | 18 | 0.280 |
Why?
| | DNA-Binding Proteins | 3 | 2013 | 1468 | 0.280 |
Why?
| | Polymorphism, Genetic | 6 | 2018 | 612 | 0.270 |
Why?
| | Hand Strength | 2 | 2021 | 149 | 0.270 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2024 | 2623 | 0.260 |
Why?
| | Hip Fractures | 2 | 2019 | 88 | 0.260 |
Why?
| | Femur Neck | 7 | 2020 | 64 | 0.260 |
Why?
| | Cardiovascular Diseases | 5 | 2018 | 2219 | 0.260 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 712 | 0.250 |
Why?
| | Leg | 1 | 2009 | 246 | 0.250 |
Why?
| | Osteoblasts | 4 | 2025 | 145 | 0.250 |
Why?
| | Aged, 80 and over | 15 | 2021 | 8391 | 0.240 |
Why?
| | Larva | 2 | 2024 | 242 | 0.240 |
Why?
| | Adult | 28 | 2025 | 41087 | 0.240 |
Why?
| | CRISPR-Cas Systems | 2 | 2024 | 163 | 0.240 |
Why?
| | Anabolic Agents | 1 | 2026 | 13 | 0.230 |
Why?
| | Picolinic Acids | 1 | 2026 | 8 | 0.230 |
Why?
| | Alleles | 10 | 2021 | 907 | 0.230 |
Why?
| | Guanylate Kinases | 1 | 2025 | 13 | 0.230 |
Why?
| | Osteogenesis | 2 | 2025 | 205 | 0.230 |
Why?
| | Risk Factors | 14 | 2025 | 10921 | 0.230 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2025 | 9 | 0.230 |
Why?
| | Transcription Factors | 2 | 2023 | 1730 | 0.220 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2025 | 19 | 0.220 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2017 | 372 | 0.220 |
Why?
| | Israel | 3 | 2025 | 45 | 0.220 |
Why?
| | Proteostasis | 1 | 2025 | 32 | 0.220 |
Why?
| | Metabolic Syndrome | 2 | 2020 | 364 | 0.220 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2024 | 6 | 0.220 |
Why?
| | Wnt Proteins | 4 | 2022 | 131 | 0.220 |
Why?
| | MyoD Protein | 1 | 2024 | 31 | 0.210 |
Why?
| | Genomic Imprinting | 3 | 2020 | 28 | 0.210 |
Why?
| | Nanoparticles | 4 | 2019 | 523 | 0.210 |
Why?
| | Evolution, Molecular | 1 | 2008 | 502 | 0.210 |
Why?
| | Gene Knockout Techniques | 1 | 2024 | 122 | 0.210 |
Why?
| | Mammals | 2 | 2023 | 288 | 0.210 |
Why?
| | Calcium | 2 | 2024 | 1181 | 0.210 |
Why?
| | Fishes | 1 | 2024 | 111 | 0.210 |
Why?
| | Menopause | 4 | 2021 | 328 | 0.200 |
Why?
| | Muscular Diseases | 1 | 2024 | 110 | 0.200 |
Why?
| | RNA-Binding Proteins | 3 | 2019 | 465 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2024 | 457 | 0.200 |
Why?
| | Muscle Development | 1 | 2024 | 114 | 0.200 |
Why?
| | Sarcomeres | 1 | 2024 | 100 | 0.200 |
Why?
| | Septins | 1 | 2024 | 43 | 0.200 |
Why?
| | Single-Cell Analysis | 1 | 2026 | 370 | 0.190 |
Why?
| | Drosophila melanogaster | 1 | 2025 | 237 | 0.190 |
Why?
| | Tartrate-Resistant Acid Phosphatase | 1 | 2022 | 6 | 0.190 |
Why?
| | Perciformes | 1 | 2023 | 20 | 0.190 |
Why?
| | Notochord | 1 | 2022 | 14 | 0.190 |
Why?
| | Cause of Death | 1 | 2005 | 456 | 0.190 |
Why?
| | Craniosynostoses | 1 | 2023 | 69 | 0.180 |
Why?
| | Genetic Association Studies | 2 | 2016 | 379 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 3 | 2019 | 156 | 0.180 |
Why?
| | Actins | 1 | 2024 | 422 | 0.180 |
Why?
| | Caenorhabditis elegans | 1 | 2026 | 330 | 0.180 |
Why?
| | Meta-Analysis as Topic | 4 | 2017 | 173 | 0.180 |
Why?
| | ADAMTS Proteins | 2 | 2019 | 6 | 0.180 |
Why?
| | Versicans | 2 | 2019 | 9 | 0.180 |
Why?
| | Vitamin D Deficiency | 2 | 2017 | 189 | 0.180 |
Why?
| | Ornithine Decarboxylase | 1 | 2021 | 12 | 0.180 |
Why?
| | Biology | 1 | 2023 | 90 | 0.180 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2019 | 25 | 0.180 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2012 | 51 | 0.180 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2022 | 128 | 0.180 |
Why?
| | Validation Studies as Topic | 1 | 2021 | 23 | 0.180 |
Why?
| | Sex Characteristics | 5 | 2012 | 801 | 0.170 |
Why?
| | Europe | 6 | 2021 | 421 | 0.170 |
Why?
| | RNA, Messenger | 2 | 2021 | 2791 | 0.170 |
Why?
| | Systems Integration | 1 | 2021 | 36 | 0.170 |
Why?
| | Osteoprotegerin | 2 | 2014 | 24 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 429 | 0.170 |
Why?
| | Ovary | 2 | 2021 | 236 | 0.170 |
Why?
| | Age Factors | 10 | 2018 | 3347 | 0.170 |
Why?
| | Methylmalonic Acid | 1 | 2021 | 66 | 0.170 |
Why?
| | DNA Repair | 2 | 2015 | 255 | 0.170 |
Why?
| | Gene Deletion | 2 | 2021 | 385 | 0.170 |
Why?
| | Vitamin B Complex | 1 | 2021 | 39 | 0.170 |
Why?
| | Muscle Contraction | 1 | 2024 | 438 | 0.170 |
Why?
| | Polyamines | 1 | 2021 | 42 | 0.160 |
Why?
| | Mice, Knockout | 3 | 2024 | 3125 | 0.160 |
Why?
| | Mannose-Binding Lectin | 1 | 2020 | 23 | 0.160 |
Why?
| | Animals, Genetically Modified | 1 | 2021 | 248 | 0.160 |
Why?
| | Carrier Proteins | 2 | 2017 | 728 | 0.160 |
Why?
| | Nitrogen | 2 | 2018 | 125 | 0.160 |
Why?
| | Education | 1 | 2021 | 103 | 0.160 |
Why?
| | Brain | 3 | 2025 | 2991 | 0.160 |
Why?
| | Reproducibility of Results | 7 | 2019 | 3416 | 0.160 |
Why?
| | Research Report | 1 | 2021 | 89 | 0.160 |
Why?
| | Ligands | 1 | 2022 | 678 | 0.160 |
Why?
| | Nerve Tissue Proteins | 1 | 2024 | 597 | 0.160 |
Why?
| | Regression Analysis | 4 | 2018 | 999 | 0.160 |
Why?
| | Muscle Weakness | 1 | 2021 | 93 | 0.150 |
Why?
| | Carbon | 2 | 2018 | 176 | 0.150 |
Why?
| | Databases, Genetic | 3 | 2024 | 239 | 0.150 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 265 | 0.150 |
Why?
| | Osteoarthritis, Hip | 1 | 2020 | 60 | 0.150 |
Why?
| | Apolipoprotein E2 | 1 | 2019 | 4 | 0.150 |
Why?
| | Nanocomposites | 1 | 2019 | 14 | 0.150 |
Why?
| | Genome | 1 | 2022 | 307 | 0.150 |
Why?
| | Jaw | 1 | 2019 | 27 | 0.150 |
Why?
| | Radiography | 5 | 2014 | 861 | 0.150 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 2019 | 17 | 0.140 |
Why?
| | Silver | 1 | 2019 | 35 | 0.140 |
Why?
| | Cortical Bone | 1 | 2019 | 18 | 0.140 |
Why?
| | Homeodomain Proteins | 2 | 2015 | 525 | 0.140 |
Why?
| | Apolipoprotein E4 | 1 | 2019 | 47 | 0.140 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2018 | 32 | 0.140 |
Why?
| | Heat-Shock Proteins | 1 | 2019 | 140 | 0.140 |
Why?
| | Ribonucleoproteins | 2 | 2017 | 106 | 0.140 |
Why?
| | Acute Disease | 1 | 2021 | 1038 | 0.140 |
Why?
| | Electric Impedance | 1 | 2019 | 108 | 0.140 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2024 | 216 | 0.140 |
Why?
| | Jews | 1 | 2018 | 18 | 0.140 |
Why?
| | Macrophages | 1 | 2026 | 1532 | 0.140 |
Why?
| | Adolescent | 13 | 2025 | 22557 | 0.140 |
Why?
| | Lipids | 1 | 2024 | 714 | 0.140 |
Why?
| | Gold | 1 | 2019 | 118 | 0.140 |
Why?
| | Wnt Signaling Pathway | 2 | 2021 | 211 | 0.140 |
Why?
| | Russia | 2 | 2016 | 12 | 0.130 |
Why?
| | Ultrasonography | 4 | 2014 | 788 | 0.130 |
Why?
| | Alveolar Bone Loss | 1 | 2017 | 9 | 0.130 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 771 | 0.130 |
Why?
| | LDL-Receptor Related Proteins | 2 | 2008 | 6 | 0.130 |
Why?
| | Cholestanetriol 26-Monooxygenase | 1 | 2017 | 7 | 0.130 |
Why?
| | Stress, Physiological | 1 | 2021 | 450 | 0.130 |
Why?
| | Musculoskeletal Development | 1 | 2017 | 5 | 0.130 |
Why?
| | Cytochrome P450 Family 2 | 1 | 2017 | 12 | 0.130 |
Why?
| | DNA Methylation | 1 | 2023 | 725 | 0.130 |
Why?
| | Exosomes | 1 | 2018 | 104 | 0.130 |
Why?
| | Muscle Strength | 2 | 2021 | 340 | 0.130 |
Why?
| | Accidental Falls | 1 | 2020 | 227 | 0.130 |
Why?
| | Chitosan | 1 | 2017 | 39 | 0.130 |
Why?
| | Drug Implants | 1 | 2017 | 83 | 0.130 |
Why?
| | Periodontitis | 1 | 2017 | 55 | 0.130 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 85 | 0.130 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 504 | 0.120 |
Why?
| | Sex Factors | 4 | 2007 | 2107 | 0.120 |
Why?
| | Strontium | 1 | 2016 | 14 | 0.120 |
Why?
| | Hydroxyapatites | 1 | 2016 | 15 | 0.120 |
Why?
| | Receptor, EphB2 | 1 | 2016 | 4 | 0.120 |
Why?
| | Excitatory Amino Acid Transporter 1 | 1 | 2016 | 6 | 0.120 |
Why?
| | Thinness | 1 | 2017 | 100 | 0.120 |
Why?
| | Spinal Curvatures | 1 | 2016 | 7 | 0.120 |
Why?
| | Biomedical Research | 2 | 2021 | 729 | 0.120 |
Why?
| | DNA Copy Number Variations | 3 | 2013 | 192 | 0.120 |
Why?
| | Calcium-Binding Proteins | 3 | 2017 | 221 | 0.120 |
Why?
| | Rats | 2 | 2023 | 5586 | 0.120 |
Why?
| | GTPase-Activating Proteins | 1 | 2016 | 81 | 0.120 |
Why?
| | Hyperostosis | 1 | 2016 | 5 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2021 | 4118 | 0.120 |
Why?
| | Societies, Medical | 1 | 2021 | 907 | 0.120 |
Why?
| | Syndactyly | 1 | 2016 | 10 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2023 | 776 | 0.120 |
Why?
| | Cadaver | 1 | 2017 | 304 | 0.120 |
Why?
| | Walking Speed | 1 | 2017 | 53 | 0.120 |
Why?
| | Weight-Bearing | 1 | 2017 | 186 | 0.120 |
Why?
| | Artificial Intelligence | 1 | 2021 | 389 | 0.120 |
Why?
| | Osteogenesis Imperfecta | 1 | 2016 | 14 | 0.120 |
Why?
| | Diphosphonates | 1 | 2016 | 68 | 0.120 |
Why?
| | Biomarkers | 3 | 2016 | 4340 | 0.120 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2017 | 55 | 0.120 |
Why?
| | Osteochondrodysplasias | 1 | 2016 | 20 | 0.120 |
Why?
| | Chromosomes, Human, Pair 6 | 2 | 2013 | 51 | 0.120 |
Why?
| | Cell Differentiation | 3 | 2025 | 1982 | 0.120 |
Why?
| | Thoracic Vertebrae | 1 | 2016 | 90 | 0.110 |
Why?
| | Breast Neoplasms | 3 | 2018 | 2418 | 0.110 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2016 | 80 | 0.110 |
Why?
| | Receptors, Neurokinin-3 | 1 | 2015 | 8 | 0.110 |
Why?
| | Laminin | 1 | 2015 | 72 | 0.110 |
Why?
| | Organ Size | 3 | 2016 | 465 | 0.110 |
Why?
| | Imidazoles | 1 | 2016 | 245 | 0.110 |
Why?
| | Program Development | 1 | 2017 | 371 | 0.110 |
Why?
| | BRCA1 Protein | 1 | 2015 | 84 | 0.110 |
Why?
| | Simulation Training | 1 | 2017 | 136 | 0.110 |
Why?
| | Computational Biology | 3 | 2021 | 678 | 0.110 |
Why?
| | Crosses, Genetic | 2 | 2012 | 120 | 0.110 |
Why?
| | Immunoglobulins | 1 | 2015 | 162 | 0.110 |
Why?
| | Hypothalamus | 1 | 2015 | 161 | 0.110 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2014 | 23 | 0.110 |
Why?
| | Sarcoplasmic Reticulum | 1 | 2014 | 37 | 0.100 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2014 | 54 | 0.100 |
Why?
| | Educational Measurement | 2 | 2017 | 331 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2021 | 641 | 0.100 |
Why?
| | Proteins | 3 | 2015 | 1022 | 0.100 |
Why?
| | Linear Models | 1 | 2016 | 857 | 0.100 |
Why?
| | Apolipoproteins E | 1 | 2014 | 97 | 0.100 |
Why?
| | Young Adult | 6 | 2025 | 14330 | 0.100 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2014 | 36 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 193 | 0.100 |
Why?
| | Massachusetts | 3 | 2012 | 178 | 0.100 |
Why?
| | Caffeine | 1 | 2014 | 77 | 0.100 |
Why?
| | Metformin | 1 | 2017 | 328 | 0.100 |
Why?
| | Cell Count | 1 | 2014 | 315 | 0.100 |
Why?
| | Calcaneus | 1 | 2014 | 32 | 0.100 |
Why?
| | Gait | 1 | 2017 | 322 | 0.100 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 209 | 0.100 |
Why?
| | Eating | 1 | 2016 | 386 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 335 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 952 | 0.090 |
Why?
| | Phosphoproteins | 2 | 2012 | 320 | 0.090 |
Why?
| | Mortality | 2 | 2014 | 375 | 0.090 |
Why?
| | Cell Death | 1 | 2014 | 379 | 0.090 |
Why?
| | Integrin alpha1 | 1 | 2012 | 2 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 539 | 0.090 |
Why?
| | Autoantigens | 1 | 2015 | 426 | 0.090 |
Why?
| | Premenopause | 1 | 2013 | 130 | 0.090 |
Why?
| | Multiple Sclerosis | 1 | 2017 | 435 | 0.090 |
Why?
| | Lod Score | 1 | 2012 | 64 | 0.090 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 28 | 0.090 |
Why?
| | Dexamethasone | 1 | 2014 | 368 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 633 | 0.090 |
Why?
| | Family | 1 | 2016 | 690 | 0.090 |
Why?
| | Environment | 1 | 2013 | 299 | 0.090 |
Why?
| | Estrogen Receptor alpha | 1 | 2013 | 154 | 0.080 |
Why?
| | Mendelian Randomization Analysis | 2 | 2022 | 68 | 0.080 |
Why?
| | Principal Component Analysis | 1 | 2012 | 192 | 0.080 |
Why?
| | Folic Acid | 2 | 2021 | 197 | 0.080 |
Why?
| | Immunity | 1 | 2012 | 141 | 0.080 |
Why?
| | Gonadal Steroid Hormones | 1 | 2012 | 143 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2011 | 190 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2018 | 2502 | 0.080 |
Why?
| | Databases, Factual | 1 | 2016 | 1493 | 0.080 |
Why?
| | Family Characteristics | 1 | 2012 | 203 | 0.080 |
Why?
| | Curriculum | 1 | 2017 | 1079 | 0.080 |
Why?
| | Pedigree | 3 | 2020 | 512 | 0.080 |
Why?
| | Body Mass Index | 6 | 2017 | 2458 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2011 | 496 | 0.080 |
Why?
| | Nuclear Proteins | 2 | 2012 | 740 | 0.080 |
Why?
| | Child | 9 | 2024 | 22693 | 0.070 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2009 | 36 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2786 | 0.070 |
Why?
| | Diet | 3 | 2021 | 1273 | 0.070 |
Why?
| | Cell Line | 1 | 2014 | 2814 | 0.070 |
Why?
| | Biomechanical Phenomena | 2 | 2016 | 874 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 430 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2134 | 0.070 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2019 | 193 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 2 | 2019 | 83 | 0.070 |
Why?
| | Metabolome | 1 | 2011 | 390 | 0.070 |
Why?
| | Testosterone | 1 | 2011 | 419 | 0.060 |
Why?
| | PPAR gamma | 1 | 2008 | 182 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2020 | 46 | 0.060 |
Why?
| | X-Ray Diffraction | 2 | 2017 | 76 | 0.060 |
Why?
| | Binding Sites | 1 | 2010 | 1309 | 0.060 |
Why?
| | Cancellous Bone | 2 | 2016 | 22 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2017 | 1942 | 0.060 |
Why?
| | Adiposity | 1 | 2011 | 533 | 0.060 |
Why?
| | Dietary Fats | 1 | 2008 | 307 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2020 | 175 | 0.060 |
Why?
| | Molecular Sequence Annotation | 2 | 2016 | 110 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2017 | 451 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2016 | 1242 | 0.060 |
Why?
| | Patient Selection | 1 | 2010 | 728 | 0.060 |
Why?
| | Age Determination by Skeleton | 1 | 2005 | 16 | 0.060 |
Why?
| | Parents | 1 | 2014 | 1394 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2007 | 1298 | 0.050 |
Why?
| | Puberty, Delayed | 1 | 2024 | 10 | 0.050 |
Why?
| | Life Expectancy | 1 | 2005 | 72 | 0.050 |
Why?
| | Puberty, Precocious | 1 | 2024 | 12 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 6073 | 0.050 |
Why?
| | Tryptophan | 1 | 2026 | 184 | 0.050 |
Why?
| | Biological Evolution | 1 | 2008 | 471 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2017 | 198 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2016 | 51 | 0.050 |
Why?
| | Obesity | 3 | 2014 | 3131 | 0.050 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 36 | 0.050 |
Why?
| | Eicosanoids | 1 | 2024 | 58 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2025 | 339 | 0.050 |
Why?
| | Motor Activity | 1 | 2008 | 704 | 0.050 |
Why?
| | Chromosomes, Human, X | 2 | 2015 | 76 | 0.050 |
Why?
| | Sphingolipids | 1 | 2024 | 83 | 0.050 |
Why?
| | Geriatric Assessment | 1 | 2005 | 244 | 0.050 |
Why?
| | CpG Islands | 1 | 2023 | 175 | 0.050 |
Why?
| | Phospholipids | 1 | 2024 | 215 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2024 | 233 | 0.040 |
Why?
| | Skull | 1 | 2023 | 162 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 3017 | 0.040 |
Why?
| | Morphogenesis | 1 | 2022 | 163 | 0.040 |
Why?
| | Heterozygote | 2 | 2014 | 311 | 0.040 |
Why?
| | Vitamin B 6 | 1 | 2021 | 11 | 0.040 |
Why?
| | Survival Analysis | 1 | 2005 | 1378 | 0.040 |
Why?
| | Age Distribution | 2 | 2016 | 399 | 0.040 |
Why?
| | Checkpoint Kinase 2 | 1 | 2021 | 27 | 0.040 |
Why?
| | Checkpoint Kinase 1 | 1 | 2021 | 27 | 0.040 |
Why?
| | Vitamins | 1 | 2023 | 183 | 0.040 |
Why?
| | Menopause, Premature | 1 | 2021 | 12 | 0.040 |
Why?
| | Reverse Genetics | 1 | 2021 | 7 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2023 | 267 | 0.040 |
Why?
| | Neoplasms | 1 | 2017 | 2954 | 0.040 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2021 | 4 | 0.040 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2021 | 40 | 0.040 |
Why?
| | HLA-DQ alpha-Chains | 1 | 2021 | 17 | 0.040 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 36 | 0.040 |
Why?
| | Healthy Aging | 1 | 2021 | 44 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2003 | 406 | 0.040 |
Why?
| | Chromosomes, Human, Pair 11 | 2 | 2011 | 61 | 0.040 |
Why?
| | Adenylyl Cyclases | 1 | 2021 | 60 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 168 | 0.040 |
Why?
| | Vitamin B 12 | 1 | 2021 | 140 | 0.040 |
Why?
| | Body Weight | 2 | 2017 | 968 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1998 | 0.040 |
Why?
| | Paternal Inheritance | 1 | 2020 | 3 | 0.040 |
Why?
| | Body Height | 2 | 2011 | 205 | 0.040 |
Why?
| | Maternal Inheritance | 1 | 2020 | 16 | 0.040 |
Why?
| | Fertility | 1 | 2021 | 174 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 227 | 0.040 |
Why?
| | Liver | 2 | 2023 | 1864 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3647 | 0.040 |
Why?
| | Health Status | 1 | 2005 | 827 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2004 | 784 | 0.040 |
Why?
| | Spectrophotometry | 1 | 2019 | 58 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2020 | 137 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 377 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 521 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 6034 | 0.040 |
Why?
| | Static Electricity | 1 | 2019 | 113 | 0.040 |
Why?
| | Adipocytes | 1 | 2021 | 223 | 0.040 |
Why?
| | Smoking | 2 | 2023 | 1486 | 0.040 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2019 | 150 | 0.040 |
Why?
| | Hydrogen Bonding | 1 | 2019 | 170 | 0.040 |
Why?
| | Prospective Studies | 3 | 2024 | 8123 | 0.040 |
Why?
| | Fracture Healing | 1 | 2019 | 92 | 0.040 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2018 | 3 | 0.040 |
Why?
| | Lasers | 1 | 2019 | 127 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2018 | 133 | 0.030 |
Why?
| | Heterografts | 1 | 2018 | 143 | 0.030 |
Why?
| | Nanostructures | 1 | 2019 | 105 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2021 | 642 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 610 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2016 | 17438 | 0.030 |
Why?
| | Amidohydrolases | 1 | 2018 | 31 | 0.030 |
Why?
| | Protein Binding | 1 | 2024 | 2244 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2019 | 477 | 0.030 |
Why?
| | Porphyromonas gingivalis | 1 | 2017 | 23 | 0.030 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 2017 | 4 | 0.030 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2017 | 18 | 0.030 |
Why?
| | Models, Genetic | 2 | 2015 | 540 | 0.030 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2017 | 28 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2921 | 0.030 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2017 | 9 | 0.030 |
Why?
| | Quantum Dots | 1 | 2017 | 37 | 0.030 |
Why?
| | Precision Medicine | 1 | 2021 | 462 | 0.030 |
Why?
| | Drug Liberation | 1 | 2016 | 36 | 0.030 |
Why?
| | Epidemiologic Studies | 1 | 2016 | 70 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2019 | 376 | 0.030 |
Why?
| | Surface Properties | 1 | 2017 | 384 | 0.030 |
Why?
| | Stem Cells | 1 | 2021 | 613 | 0.030 |
Why?
| | Bone Remodeling | 1 | 2016 | 71 | 0.030 |
Why?
| | Kyphosis | 1 | 2016 | 37 | 0.030 |
Why?
| | Adsorption | 1 | 2016 | 154 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 139 | 0.030 |
Why?
| | Animal Feed | 1 | 2016 | 50 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 2017 | 129 | 0.030 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 175 | 0.030 |
Why?
| | Materials Testing | 1 | 2017 | 345 | 0.030 |
Why?
| | Breeding | 1 | 2016 | 64 | 0.030 |
Why?
| | China | 1 | 2016 | 280 | 0.030 |
Why?
| | Penetrance | 1 | 2015 | 30 | 0.030 |
Why?
| | Genes, X-Linked | 1 | 2015 | 21 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2015 | 46 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2019 | 442 | 0.030 |
Why?
| | Amides | 1 | 2015 | 100 | 0.030 |
Why?
| | Hypogonadism | 1 | 2015 | 89 | 0.030 |
Why?
| | Forkhead Box Protein O3 | 1 | 2014 | 18 | 0.030 |
Why?
| | Receptors, GABA-B | 1 | 2014 | 10 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1203 | 0.030 |
Why?
| | Receptors, Retinoic Acid | 1 | 2014 | 44 | 0.030 |
Why?
| | Exercise | 1 | 2006 | 2213 | 0.030 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2014 | 12 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 11913 | 0.030 |
Why?
| | Exome | 1 | 2015 | 233 | 0.030 |
Why?
| | Chromosome Breakpoints | 1 | 2013 | 9 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 951 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2012 | 1792 | 0.030 |
Why?
| | Netherlands | 1 | 2014 | 85 | 0.030 |
Why?
| | Reproduction | 1 | 2015 | 209 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 49 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1543 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 467 | 0.020 |
Why?
| | Cattle | 1 | 2016 | 940 | 0.020 |
Why?
| | RNA Interference | 1 | 2015 | 472 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2015 | 334 | 0.020 |
Why?
| | Markov Chains | 1 | 2013 | 129 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2014 | 180 | 0.020 |
Why?
| | Gene Dosage | 1 | 2013 | 146 | 0.020 |
Why?
| | Rural Population | 1 | 2018 | 677 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2081 | 0.020 |
Why?
| | Biopsy | 1 | 2016 | 1075 | 0.020 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2014 | 204 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 410 | 0.020 |
Why?
| | Spectrin | 1 | 2012 | 13 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1463 | 0.020 |
Why?
| | Endonucleases | 1 | 2012 | 35 | 0.020 |
Why?
| | Genes | 1 | 2012 | 215 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2012 | 8 | 0.020 |
Why?
| | Perilipin-4 | 1 | 2011 | 1 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2011 | 16 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2012 | 67 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 460 | 0.020 |
Why?
| | DNA Repair Enzymes | 1 | 2012 | 29 | 0.020 |
Why?
| | Exodeoxyribonucleases | 1 | 2012 | 23 | 0.020 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2012 | 48 | 0.020 |
Why?
| | DNA Primase | 1 | 2012 | 47 | 0.020 |
Why?
| | Microfilament Proteins | 1 | 2012 | 136 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2011 | 47 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 630 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1331 | 0.020 |
Why?
| | Subcutaneous Fat | 1 | 2011 | 80 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 45 | 0.020 |
Why?
| | DNA Helicases | 1 | 2012 | 138 | 0.020 |
Why?
| | Chromosomes, Human, Pair 4 | 1 | 2010 | 26 | 0.020 |
Why?
| | Serrate-Jagged Proteins | 1 | 2010 | 27 | 0.020 |
Why?
| | Jagged-1 Protein | 1 | 2010 | 22 | 0.020 |
Why?
| | Glycoproteins | 1 | 2012 | 356 | 0.020 |
Why?
| | Homozygote | 1 | 2010 | 197 | 0.020 |
Why?
| | Immunoassay | 1 | 2010 | 108 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 90 | 0.020 |
Why?
| | International Cooperation | 1 | 2010 | 193 | 0.020 |
Why?
| | Adiponectin | 1 | 2011 | 243 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2010 | 329 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2015 | 930 | 0.020 |
Why?
| | Sexual Maturation | 1 | 2009 | 49 | 0.020 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2009 | 41 | 0.020 |
Why?
| | Canada | 1 | 2010 | 432 | 0.020 |
Why?
| | Algorithms | 1 | 2016 | 1849 | 0.020 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2008 | 4 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2008 | 252 | 0.020 |
Why?
| | RANK Ligand | 1 | 2008 | 29 | 0.020 |
Why?
| | Lung | 1 | 2021 | 4122 | 0.020 |
Why?
| | Seasons | 1 | 2010 | 540 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1077 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2010 | 587 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2018 | 6460 | 0.010 |
Why?
| | Psychiatric Nursing | 1 | 1985 | 9 | 0.010 |
Why?
| | Prevalence | 1 | 2012 | 2861 | 0.010 |
Why?
| | Calcium, Dietary | 1 | 2004 | 52 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2010 | 1432 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2003 | 40 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1031 | 0.010 |
Why?
| | Bone Resorption | 1 | 2004 | 81 | 0.010 |
Why?
| | Infant | 1 | 2018 | 10114 | 0.010 |
Why?
| | Homocysteine | 1 | 2003 | 152 | 0.010 |
Why?
| | Turkmenistan | 1 | 2002 | 1 | 0.010 |
Why?
| | Blood Glucose | 1 | 2012 | 2360 | 0.010 |
Why?
| | Postmenopause | 1 | 2004 | 394 | 0.010 |
Why?
| | Fingers | 1 | 2002 | 106 | 0.010 |
Why?
| | Insulin | 1 | 2012 | 2525 | 0.010 |
Why?
| | Life Style | 1 | 2004 | 496 | 0.010 |
Why?
| | Estrogens | 1 | 2004 | 364 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2010 | 5439 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 7109 | 0.010 |
Why?
| | United States | 1 | 2010 | 16136 | 0.010 |
Why?
| | Counseling | 1 | 1985 | 406 | 0.000 |
Why?
|
|
Karasik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|